Next Article in Journal
Xeomin®, a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
Next Article in Special Issue
Mycotoxins’ Prevalence in Food Industry By-Products: A Systematic Review
Previous Article in Journal
The Bright and Dark Sides of Herbal Infusions: Assessment of Antioxidant Capacity and Determination of Tropane Alkaloids
Previous Article in Special Issue
Toxicokinetics of a Single Oral Dose of OTA on Dezhou Male Donkeys
 
 
Review

Article Versions Notes

Action Date Notes Link
article xml file uploaded 28 March 2023 11:34 CEST Original file -
article xml uploaded. 28 March 2023 11:34 CEST Update https://www.mdpi.com/2072-6651/15/4/246/xml
article pdf uploaded. 28 March 2023 11:34 CEST Version of Record https://www.mdpi.com/2072-6651/15/4/246/pdf
article html file updated 28 March 2023 11:36 CEST Original file -
article html file updated 6 April 2023 23:08 CEST Update https://www.mdpi.com/2072-6651/15/4/246/html
Back to TopTop